Vis enkel innførsel

dc.contributor.authorEngell, Sarah Ellinor
dc.contributor.authorBengtsson, Henrik
dc.contributor.authorDavari Benam, Karim
dc.contributor.authorFougner, Anders Lyngvi
dc.contributor.authorJørgensen, John Bagterp
dc.date.accessioned2023-11-14T08:32:47Z
dc.date.available2023-11-14T08:32:47Z
dc.date.created2023-09-27T10:43:02Z
dc.date.issued2023
dc.identifier.isbn979-8-3503-3544-6
dc.identifier.urihttps://hdl.handle.net/11250/3102312
dc.description.abstractIn late-stage type 2 diabetes, automated titration algorithms provide a promising alternative to the current standard-of-care. Many published methods rely on personalized dose-response models to predict a safe and effective insulin dose. In this case study, we address the challenge of how to collect an informative data set to ensure practical identifiability of such models. We apply optimal experimental design to enhance the performance of a published titration algorithm. For a 24-hour experiment, we solve an optimization problem to select the size of three meals and the hourly fast-acting insulin infusion rate. In simulation, we demonstrate how the optimized protocol improves the safety of the algorithm’s dose-predictions. The results indicate that optimal experimental design has the potential to improve model-based algorithms and may be used as a qualitative tool when planning clinical experiments.en_US
dc.language.isoengen_US
dc.publisherIEEEen_US
dc.relation.ispartofProceedings of the 2023 IEEE Conference on Control Technology and Applications (CCTA)
dc.relation.urihttps://ieeexplore.ieee.org/document/10252530
dc.subjectOptimal eksperimentdesignen_US
dc.subjectOptimal experimental designen_US
dc.subjectInsulinresistensen_US
dc.subjectInsulin resistanceen_US
dc.subjectEksperiment-designen_US
dc.subjectDesign of experimentsen_US
dc.subjectDiabetes type 2en_US
dc.subjectDiabetes type 2en_US
dc.titleOptimal Experimental Design to Estimate Insulin Response in Type 2 Diabetesen_US
dc.title.alternativeOptimal Experimental Design to Estimate Insulin Response in Type 2 Diabetesen_US
dc.typeChapteren_US
dc.description.versionacceptedVersionen_US
dc.rights.holder© Copyright 2023 IEEE - All rights reserveden_US
dc.subject.nsiVDP::Medisinsk teknologi: 620en_US
dc.subject.nsiVDP::Medical technology: 620en_US
dc.source.pagenumber540-545en_US
dc.identifier.doi10.1109/CCTA54093.2023.10252530
dc.identifier.cristin2179299
dc.relation.projectNovo Nordisk Fonden: 0153-00049Ben_US
cristin.ispublishedtrue
cristin.fulltextpostprint


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel